Blood thinner safety during cancer surgery
Part of Cancer, Heart & circulation clinical trials.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are taking a blood thinner for atrial fibrillation or a blood clot, such as apixaban, rivaroxaban, edoxaban, dabigatran, warfarin, or a heparin shot.
- You have active cancer (diagnosed in the last 6 months, or cancer that has spread, or you received cancer treatment in the last 6 months).
- You need to pause your blood thinner for a planned cancer-related surgery or procedure.
- You do not have a mechanical heart valve, severe kidney problems, or a history of heparin allergy or heparin-induced low platelets.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different ways to take the blood thinner apixaban to prevent blood clots in people with cancer who are starting or switching their cancer treatment. It aims to find the best dose for safety and effectiveness.
This trial tests whether continuing a lower dose of blood thinners can prevent another blood clot in cancer patients who have had a clot in an arm or chest catheter. It may help find a safer way to prevent future clots.
This study tests a plan for how cancer patients taking blood thinners (called DOACs) should handle their medication before and after getting a central line (a special IV tube placed in a large vein for treatments). The goal is to find a safe way to prepare for the procedure without increasing the risk of bleeding or blood clots.
This study looks at how to safely manage your blood thinner (DOAC) around the time of a planned, high-bleed-risk surgery or procedure involving a spinal needle. The goal is to find the best way to stop and restart your medication to prevent bleeding and clotting problems.
This trial tests whether a medication called apixaban (a blood thinner) can safely prevent blood clots after abdominal or pelvic surgery. It is for people who have a moderate risk of clots and bleeding, and who are not taking other blood thinners.
This trial tests whether a daily pill called edoxaban can prevent blood clots that sometimes form around a central venous catheter in people with cancer. If it works, it could lower the risk of a dangerous clot without major side effects.
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.